Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples